Urolithiasis 2 pp 193-195 | Cite as

Urinary Glycosaminoglycans Differ in their Calcium Oxalate Crystallization Activities

  • M. D. I. Gohel
  • D. K. Y. Shum


Various studies have indicated that urinary macromolecules exhibit diverse activities towards calcium oxalate crystallization1, 2. One group of these macromolecules, the glycosaminoglycans (GAGs), has been shown to affect calcium oxalate crystallization3, 4. Our interest in GAGs stems from previous evidence that urinary polyanions exhibit differences towards crystallization of urinary calcium oxalate between normal controls and stone-formers5 and further to this, Reference standard GAGs (obtained from non-urinary sources) appear to behave differently from urinary GAGs6. The present study indicates that urinary GAG classes from normals and stone formers influence crystallization differently, though electrophoretically they appear similar.


Heparan Sulphate Calcium Oxalate Calcium Oxalate Crystal Uronic Acid Content Barium Acetate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    T Koide, M Takemoto, H Itatani, M Takaha and T Sonoda, Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation, Invest Urol 18(5): 382 (1981).PubMedGoogle Scholar
  2. 2.
    GH Nancollas, S A Smesko, AA Campbell, M Coyle-Rees, A Ebrahimpour, M Binette and JP Binette. Mineralization inhibitors and promoters, in: “Urolithiasis” VR Walker, RAL Sutton, ECB Cameron, CYC Pak and WG Robertson (ed) Springer Science+Business Media New York (1989).Google Scholar
  3. 3.
    K Kohri, J Garside and NJ Blacklock, The effect of glycosaminoglycans on the crystallization of calcium oxalate, Br J Urol 63: 584 (1989).PubMedCrossRefGoogle Scholar
  4. 4.
    AH Angell and MI Resnick, Surface interaction between glycosaminoglycans and calcium oxalate, J Urol 141: 1255 (1989).PubMedGoogle Scholar
  5. 5.
    MD Gohel, DKY Shum and MK Li, The dual effect of urinary macromolecules on the crystallization of calcium oxalate endogenous in urine, Urol Res 20: 12 (1992).CrossRefGoogle Scholar
  6. 6.
    DKY Shum, KF Wu and SW Wong, Crystallization of urinary calcium oxalate. Effects of added calcium, oxalate or commercial glycosaminoglycans (GAGs), in: Book of Abstracts of the 9th Symposium of the Federation of Asian and Oceanian Biochemists, Hong Kong Biochemical Association (Organizers), Hong Kong (1991).Google Scholar
  7. 7.
    LS Cornish, TRC Boyde, YC Chung and CS Ng, A microcontroller-based flat bed preparative electrophoresis apparatus, Lab Practice 36: 35 (1987).Google Scholar
  8. 8.
    DKY Shum and E Liong, Calcium oxalate crystallizing properties of macromolecules released by renal tubular cells in vitro, in this volume.Google Scholar
  9. 9.
    RL Ryall, RM Harnett and VR Marshall,The effect of monosodium urate on the capacity of urine, chondroitin sulphate and heparin to inhibit calcium oxalate crystal growth and aggregation, J Urol 135: 174 (1986).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • M. D. I. Gohel
    • 1
  • D. K. Y. Shum
    • 1
  1. 1.Dept. of Biochemistry, Faculty of MedicineThe University of Hong KongHong Kong

Personalised recommendations